Engaging African American men as citizen scientists to validate a prostate cancer biomarker: Work-in-progress

Karriem S. Watson, University of Illinois at Chicago
Vida Henderson, University of Illinois at Chicago
Marcus Murray, Project Brotherhood
Adam B. Murphy, Northwestern University
Josef Ben Levi, Northeastern Illinois University
Tiffany McDowell, Health Alliance
Alfreda Holloway-Beth, Project Brotherhood
Pooja Gogana, Northwestern University Feinberg School of Medicine
Michael A. Dixon, Northwestern University Feinberg School of Medicine
Leandre Moore, Health Alliance
Ivanhoe Hall, University of Illinois at Chicago
Alexander Kimbrough, University of Illinois at Chicago
Yamilé Molina, University of Illinois at Chicago
Robert A. Winn, University of Illinois at Chicago

Abstract

Background: African American men (AAM) are underrepresented in prostate cancer (PCa) research despite known disparities. Screening with prostate-specific antigen (PSA) has low specificity for high-grade PCa leading to PCa over diagnosis. The Prostate Health Index (PHI) has higher specificity for lethal PCa but needs validation in AAM. Engaging AAM as citizen scientists (CSs) may improve participation of AAM in PCa research. Objectives: Assess feasibility of mobilizing CSs to recruit AAM as controls for PHI PCa validation biomarker study. Methods: We highlight social networks/assets of stakeholders, CSs curriculum development/implementation, and recruitment of healthy controls for PHI validation. Results and Lessons Learned: Eight CSs completed all training modules and 139 AAM were recruited. Challenges included equity in research leadership among multiple principal investigators (PIs) and coordinating CSs trainings. Conclusions: Engaging AAM CSs can support engaging/ recruiting AAM in PCa biomarker validation research. Equity among multiple stakeholders can be challenging, but proves beneficial in engaging AAM in research.